BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37980495)

  • 1. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
    Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
    BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
    Jiang Y; Zhang C; Zhang J; Han D; Shi X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of interferon induced protein with tetratricopeptide repeats (IFIT) family in autoimmune disease.
    Wu YY; Xing J; Li XF; Yang YL; Shao H; Li J
    Autoimmun Rev; 2023 Nov; 22(11):103453. PubMed ID: 37741527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer.
    Tan XF; Chen Q; Hua SH; Yip GW
    Curr Med Chem; 2021; 28(25):5034-5047. PubMed ID: 34139972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
    Shi H; Gao L; Zhang W; Jiang M
    BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
    Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon induced IFIT family genes in host antiviral defense.
    Zhou X; Michal JJ; Zhang L; Ding B; Lunney JK; Liu B; Jiang Z
    Int J Biol Sci; 2013; 9(2):200-8. PubMed ID: 23459883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
    Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
    BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma.
    Jiang Y; Han D; Zhao Y; Zhang C; Shi X; Gu W
    Front Immunol; 2022; 13():872170. PubMed ID: 35558077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
    Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
    Front Genet; 2022; 13():804614. PubMed ID: 35615374
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Functions of Human IFIT Proteins in Cancer.
    Pidugu VK; Pidugu HB; Wu MM; Liu CJ; Lee TC
    Front Mol Biosci; 2019; 6():148. PubMed ID: 31921891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia.
    Xu Q; Guo T
    Hematology; 2022 Dec; 27(1):659-671. PubMed ID: 35666642
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
    He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
    Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker.
    Wu Z; Liu X; Xie F; Ma C; Lam EW; Kang N; Jin D; Yan J; Jin B
    Life Sci; 2024 Apr; 343():122527. PubMed ID: 38417544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA.
    Fleith RC; Mears HV; Leong XY; Sanford TJ; Emmott E; Graham SC; Mansur DS; Sweeney TR
    Nucleic Acids Res; 2018 Jun; 46(10):5269-5285. PubMed ID: 29554348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
    Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
    BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations].
    Xia PH; Xu ZJ; Jin Y; Ma JC; Wen XM; Yuan Q; Leng JY; Qian J; Lin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):659-670. PubMed ID: 35680788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of immune checkpoints in acute myeloid leukemia.
    Chen C; Liang C; Wang S; Chio CL; Zhang Y; Zeng C; Chen S; Wang C; Li Y
    J Hematol Oncol; 2020 Apr; 13(1):28. PubMed ID: 32245463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.